Evaluating Sempra: Insights From 6 Financial Analysts
Portfolio Pulse from Benzinga Insights
Sempra (NYSE:SRE) has been analyzed by 6 financial analysts, showing a range of opinions from bullish to bearish. The average 12-month price target is $79.42, with a high of $86.00 and a low of $73.00, indicating a 3.68% increase from the previous target. Analysts from Barclays, BMO Capital, Ladenburg Thalmann, JP Morgan, and Morgan Stanley have adjusted their ratings and price targets, reflecting their views on Sempra's market position and financial health. Sempra's market cap is above industry average, but it saw a -7.82% decline in revenue growth. However, it maintains strong net margin, ROE, and ROA, with a moderate debt-to-equity ratio.
January 22, 2024 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Sempra's stock may see a positive short-term impact due to the overall positive analyst ratings and increased average price target, despite a recent decline in revenue growth.
The positive sentiment from analysts, including raised price targets from firms like Barclays and JP Morgan, suggests confidence in Sempra's financial health and market position. This could lead to increased investor confidence and a potential rise in stock price. However, the recent revenue decline may temper gains, hence the importance is not at the maximum.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100